Wall Street expects the company to report a 7.9% increase in earnings per share to $5.08, on a revenue of $8.87B, up 8.2% from last year. Analysts at BMO Capital Markets expect Amgen’s 2025 ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year. The company faces significant patent expiries but aims to offset losses ...

The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Investors can cash in by ...

Amgen (AMGN) concluded the recent trading session at $318.65, signifying a +0.47% move from its prior day's close.

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...

MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...

Research analysts at William Blair issued their Q1 2026 EPS estimates for shares of Amgen in a research note issued on Wednesday, March 5th. William Blair analyst M. Phipps anticipates that the ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Amgen is expected to post earnings of $4.18 per ...

Investment analysts at William Blair issued their Q4 2026 earnings per share estimates for Amgen in a research report issued ...